AROG — Arog Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Arog Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -12.1 | -11.6 |
| Depreciation | ||
| Non-Cash Items | 6.98 | 5.44 |
| Other Non-Cash Items | ||
| Changes in Working Capital | 0.886 | 0.476 |
| Change in Prepaid Expenses | ||
| Change in Accrued Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Cash from Operating Activities | -4.16 | -5.63 |
| Financing Cash Flow Items | — | 3 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 4 | 5 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -0.156 | -0.631 |